Capsule Summary Slidesets

Share

Program Content

Activities

  • CARISEL Clinical Outcomes
    CARISEL: Clinical Outcomes by Implementation Strategy of Patients Receiving LA CAB + RPV in European Healthcare Settings
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 26, 2022

    View Activity
  • PrEP Survey in US Women
    Survey of PrEP Interest, Usage, and Awareness Among US Cisgender Women
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 26, 2022

    View Activity
  • HPTN 083 Update
    HPTN 083: HIV Infections in the Yr 1 Unblinded Period in MSM and TGW Receiving Injectable CAB for HIV PrEP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 27, 2022

    View Activity
  • Factors Associated With Virologic Failure in LA ART
    ATLAS, ATLAS-2M, and FLAIR Pooled Analysis: Factors Associated With Virologic Failure in PWH Receiving LA CAB + RPV Using Expanded Multivariable Models
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 28, 2022

    View Activity
  • Optimal ISL Daily Dose
    Selection of Optimal Islatravir Doses for Persons With HIV Naive to Treatment and Switching From Stable Therapy Through Modeling and Simulation
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 01, 2022

    View Activity
  • OPERA: Real-world LA CAB + RPV
    Real-world Effectiveness of Long-Acting CAB + RPV in the First Yr in the US OPERA Cohort
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 01, 2022

    View Activity
  • CAPELLA: LEN in MDR HIV
    CAPELLA: Wk 52 Results With Long-Acting SC Lenacapavir in Randomized and Nonrandomized Cohorts of Persons With Multidrug-Resistant HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2022

    View Activity
  • BANNER Study
    BANNER Study: Broadly Neutralizing Antibody VH3810109 in People With HIV Naive to Treatment
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 04, 2022

    View Activity
  • BICSTaR: BIC/FTC/TAF Effectiveness
    BICSTaR: BIC/FTC/TAF Effectiveness and Safety by Demographics and Baseline Characteristics at 24 Mo
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 07, 2022

    View Activity
  • Islatravir Lymphocyte Changes
    Protocol 011: Post Hoc Analysis of Lymphocyte Changes in PWH Receiving Islatravir
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2022

    View Activity

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare